Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Associated with Pediatric Infection in Cambodia by Chheng, Kheng et al.
Emergence of Community-Associated Methicillin-
Resistant Staphylococcus aureus Associated with
Pediatric Infection in Cambodia
Kheng Chheng
1, Sarah Tarquinio
1, Vanaporn Wuthiekanun
2, Lina Sin
1, Janjira Thaipadungpanit
2,
Premjit Amornchai
2, Ngoun Chanpheaktra
1, Sarinna Tumapa
2, Hor Putchhat
1, Nicholas P. J. Day
2,3,
Sharon J. Peacock
2,3,4*
1Angkor Hospital for Children, Siem Reap, Kingdom of Cambodia, 2Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand, 3Centre for
Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom, 4Department of Medicine, University
of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdom
Abstract
Background: The incidence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection is
rising in the developed world but appears to be rare in developing countries. One explanation for this difference is that
resource poor countries lack the diagnostic microbiology facilities necessary to detect the presence of CA-MRSA carriage
and infection.
Methodology and Principal Findings: We developed diagnostic microbiology capabilities at the Angkor Hospital for
Children, Siem Reap, western Cambodia in January 2006 and in the same month identified a child with severe community-
acquired impetigo caused by CA-MRSA. A study was undertaken to identify and describe additional cases presenting
between January 2006 and December 2007. Bacterial isolates underwent molecular characterization using multilocus
sequence typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for the presence of the genes
encoding Panton-Valentine Leukocidin (PVL). Seventeen children were identified with CA-MRSA infection, of which 11 had
skin and soft tissue infection and 6 had invasive disease. The majority of cases were unrelated in time or place. Molecular
characterization identified two independent MRSA clones; fifteen isolates were sequence type (ST) 834, SCCmec type IV, PVL
gene-negative, and two isolates were ST 121, SCCmec type V, PVL gene-positive.
Conclusions: This represents the first ever report of MRSA in Cambodia, spread of which would pose a significant threat to
public health. The finding that cases were mostly unrelated in time or place suggests that these were sporadic infections in
persons who were CA-MRSA carriers or contacts of carriers, rather than arising in the context of an outbreak.
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Introduction
Infections caused by methicillin-resistant Staphylococus aureus
(MRSA) are a major scourge of modern medical care in the
developed world [1]. For many years after its emergence, MRSA
was associated with carriage or infection in the hospital setting
where strains flourished due to the selection pressure of antibiotics
but failed to become established in the community setting. A
changing pattern of disease epidemiology was signalled by reports
from the United States in the late 1990’s of MRSA infection in
otherwise healthy children who lacked exposure to an institutional
health care setting or other risk factors typically associated with
MRSA colonization [2,3]. Community-associated (CA)-MRSA has
since become disseminated across much of the developed world [4–
13], and is a leading cause of bacterial infection in otherwise healthy
persons in the United States where it causes the majority of all skin
and soft tissue infections in patients presenting to emergency
departments [14,15]. Most CA-MRSA infections are relatively
minor, but more serious manifestations include necrotizing fasciitis,
pyomyositis, osteoarticular infections, and community-acquired
pneumonia including severe and often fatal necrotizing pneumonia.
Characterisation of CA-MRSA isolated from a wide geographic
distribution has indicated that these strains are often relatively
susceptible to antimicrobials compared with their hospital-associat-
ed MRSA counterparts. Most strains carry a small variant of the
methicillin-resistance cassette (SCCmec type IV or less often type V)
[4,7,10–13,16], and are frequently although not universally positive
for the genes encoding Panton-Valentine leukocidin (PVL) [7,13], a
two-component leukolytic toxin associated with skin and soft tissue
infections and more severe infections such as necrotizing pneumo-
nia [17,18]. Genetic comparison of a collection of CA-MRSA using
multilocus sequence typing (MLST) has indicated that strains with
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strains with unrelated genetic backgrounds, indicative of multiple
independent clonal origins [7].
Resource-restricted Asia has largely been spared from CA-
MRSA to date, despite the ready availability of over-the-counter
antibiotics and frequent self-medication. The dissemination of CA-
MRSA into rural Asia would represent a major threat to health.
Diagnostic microbiology is often lacking and so MRSA would go
unrecognised, health care including access to expensive antibiotics
is restricted, and a large proportion of health care is provided by
traditional healers or untrained personnel working in local
dispensaries. Here, we report the identification of two independent
clones of CA-MRSA associated with mild and severe infections in
children presenting to the Angkor Hospital for Children (AHC) in
Siem Reap, Cambodia. Infections appeared to be sporadic rather
than related to an outbreak, suggesting that they were associated
with endemic carriage of the causative strains in the community.
Methods
Ethics statement
The study protocol was reviewed and approved by the Ethical
Review Board of the Angkor Hospital for Children. The Ethical
Review Board deemed consent unnecessary for this retrospective
study.
Setting and Patients
The study was conducted at the AHC, an NGO-funded
teaching hospital in Siem Reap, situated in the province of Siem
Reap, northwest Cambodia. This city has a population of 140,000
people and is the fastest growing city in the country, a result of
tourism to the nearby Angkor Wat temples. The AHC provides
free outpatient, inpatient, emergency, surgical, medical, ophthal-
mological and dental care, and maintains 50 inpatient beds spread
across high, medium and low intensity care areas. The outpatient
department sees an average of approximately 400 children each
day from an unrestricted catchment area, the majority of who live
in three neighbouring provinces (Siem Reap, Battambang and
Banteay Meanchey). Cambodia is a highly impoverished country,
as reflected by recent socio-economic indicators. For example, in
2006 the mortality rate for children under 5 was 93 per 1,000 live
births, the prevalence of malnutrition in the same age group was
28%, and life expectancy at birth was 59 years [19].
Laboratory-based surveillance was conducted between January
2006 and December 2007 to identify children presenting to in- or
outpatient departments with one or more microbiological samples
positive for MRSA. A retrospective review of case records was
performed at the end of this period to collect information on age,
gender, area of residence, whether admitted, diagnosis at
presentation, site of S. aureus infection, antimicrobial therapy (type,
route and duration), infection associated procedures, duration of
hospital stay and outcome at hospital discharge. Sites of S. aureus
infection were established based on a record of history and
examination findings in the medical notes, together with
investigation reports and operation notes. CA-MRSA was defined
as an MRSA isolate recovered from a patient with S. aureus
infection that developed in the community or within 48 hours of
hospital admission, in the absence of established risk factors for
MRSA infection [4,6,9].
Microbiological methods
S. aureus was identified based on the catalase, coagulase and a
commercial slide agglutination test (Staphaurex Plus, Oxoid).
Susceptibilities to penicillin, oxacillin, erythromycin, trimetho-
prim-sulfamethoxazole, gentamicin and ciprofloxacin were tested
by the hospital laboratory at the time of strain isolation using the
disk diffusion method [20], and reported to treating physicians.
Isolates were stored in TSB with 20% glycerol at 280uC. An
extended antimicrobial susceptibility profile was later determined
using the disk diffusion method to establish susceptibilities to other
antimicrobial agents with potential activity against the clinical
isolates. This panel was cefoxitin, chloramphenicol, ciprofloxacin,
clindamycin, erythromycin, fusidic acid, gentamicin, mupirocin,
netilmicin, penicillin, rifampicin, trimethoprim-sulfamethoxazole,
tetracycline and vancomycin. Isolates that were resistant to
cefoxitin by disk diffusion were evaluated by oxacillin and
vancomycin E-tests (AB Biodisk). Inducible clindamycin resistance
was determined as described previously [21].
Molecular characterization of S. aureus
Genomic DNA was extracted from a 1 ml overnight culture of
S. aureus with an optical density of 1.0 at 600 nm using the High
Pure PCR Template Preparation Kit (Roche Applied Science,
Germany), with an additional step of incubation at 37uC for 30
minutes with 0.5 ml of lysostaphin solution (10 mg/ml, Sigma,
USA) prior to cell lysis. SCCmec type assignment was performed
using a multiplex PCR method, as described previously [22].
Presence of the genes encoding PVL (lukF-PV and lukS-PV) was
determined by PCR as described by Lina et al. [18]. MLST was
performed as described by Enright et al. [23]. Sequence type (ST)
assignment was based on the sequence of the alleles at each locus
of seven housekeeping genes using the MLST database (www.mlst.
net). STs were assigned to their clonal complex using the program
eBURST (http://eburst.mlst.net) and the entire MLST database.
Results
In December 2005, a 9 month old child presented to the
outpatient department with impetigo of the outer ear and acute
otitis media. The child was previously fit and well and had not
been seen previously at the AHC. Culture facilities were not
available, a Gram-stain of pus obtained from the skin showed
Gram-positive cocci in clusters consistent with staphylococci and
the child was sent home with oral cloxacillin. The child was seen
again the following month with severe impetigo and acute otitis
media. Diagnostic microbiology capabilities became available at
the AHC in January 2006 and a swab taken from the impetigo
grew MRSA. The child was admitted and made a rapid clinical
response to clindamycin and gentamicin plus topical fusidic acid.
An observational study between January 2006 and December
2007 identified a further 16 children with infections caused by
MRSA. The age of the 17 children ranged from 8 months to 14
years 6 months (median 4 years 8 months), 7 (39%) of who were
boys. Eleven children had skin and soft tissue infection, and 6
children had invasive disease (positive blood culture and no other
focus,2 cases;osteomyelitis(onecase complicated bypyomyositis), 2
cases; septic arthritis, 1 case; and pneumonia and empyema, 1 case).
Five children were treated in the outpatient department alone,
and 12 were admitted to the AHC for a median duration of 13
days (range 2 to 25 days). Surgical procedures were performed on
7 children, including incision and drainage (n=3), osteotomy for
ostemyelitis (n=2), joint washout for septic arthritis (n=1), and
chest drain insertion for empyema (n=1). All 17 children were
initially treated with first-line empiric therapy according to their
admission diagnosis, with cloxacillin being the most common
(n=8). Therapy was modified thereafter based on the hospital
antimicrobial susceptibility results, including ciprofloxacin in 11
cases. Extended antimicrobial susceptibility profiles defined at the
end of the study are shown in Table 1.
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child with MRSA-infected eczema re-presented 7 months later
with rapidly progressive pneumonia and sepsis that led to death on
day 2 of admission. MRSA was not isolated on this admission and
the bacterial pathogen responsible was not identified. Cure was
recorded for 14 of the 16 remaining children, while 2 children
treated in outpatients were lost to follow up before culture results
were available and outcome was unknown.
The source of MRSA acquisition was considered. Most children
(16/17, 94%) had MRSA isolated from cultures taken within
48 hours of presentation and had no known risk factors for
nosocomially acquired MRSA colonisation or infection. The
remaining case was admitted with severe impetigo and was initially
treated empirically with cloxacillin. A skin swab taken for the first
time on day 6 because of failure to respond to antimicrobial
therapy was positive for MRSA. There was an overlap of 3 days
between this patient and a second inpatient who was receiving
vancomycin for MRSA bacteremia in the absence of a known
focus and who was blood culture negative on the day that the child
with impetigo was admitted. The two isolates were the same
genotype (sequence type (ST) 834, see below) but had variable
susceptibility to erythromycin and clindamycin. We conclude that
16 cases were definite community-associated infections, and that
the remaining case was most likely to have been community-
associated.
Place of residence and timing of infection were examined to
assess whether the 17 cases represented sporadic infection or
whether they were related to one or more community-based
outbreaks. Thirteen children resided in different villages scattered
across 3 neighbouring provinces (Figure 1) and were very unlikely
to have had access to any mode of transport or the opportunity to
meet. Two different pairs of unrelated children lived in the same
village. The first pair from a village in Banteay Meanchey province
presented 23 days apart, and the second pair from a village in
Siem Reap province presented 120 days apart. Each pair of
children was unrelated and did not live at the same address, but it
is not known whether they came into contact with each other.
Molecular characterisation of the 17 MRSA isolates demon-
strated that 15 patients were infected with a strain that was
designated as ST 834, SCCmec IV, PVL gene-negative. ST 834
has been isolated previously on three occasions during 2006 in
Western Australia where it is considered to represent CA-MRSA
and is colloquially known as WA MRSA-41 (personal communi-
cation, Geoff Coombs, Royal Perth Hospital). ST 834 belongs to
clonal complex (CC) 9 and is a single locus variant of MRSA ST
671, which was isolated previously in Queensland in 2004. The
remaining two patients were infected by isolates that were
designated as ST 121, SCCmec type V, PVL gene-positive. The
two patients infected with ST 121 lived approximately 100 km
apart and were unrelated. ST 121 is the predicted founder of CC
121. ST 834 and ST 121 represent CA-MRSA in novel genetic
backgrounds, since none of the previously described CA-MRSA
clones belong to either of these clonal complexes. Methicillin-
susceptible S. aureus (MSSA) ST 121 has been identified previously
in the UK and Thailand, and MRSA ST 121 has been isolated in
China. MLST performed by us of twenty unselected MSSA strains
isolated at the AHC over the same period demonstrated that ST
121 was the largest clone and represented 12 (60%) of those tested
(data not otherwise shown). The antimicrobial susceptibility
pattern of MSSA ST 121 and MRSA ST 121 were comparable
(data not shown), and were less antibiotic-resistant than ST 834,
being susceptible to trimethoprim-sulphamethoxazole, ciprofloxa-
cin and rifampicin against which ST 834 was resistant.
Discussion
Published reports of CA-MRSA isolation in resource-restricted
Asia are rare. An outbreak of vaccination-associated infection has
been reported from Ho Chi Minh city, Vietnam caused by an
isolate of CA-MRSA carried by a healthcare worker that was
defined as ST 59, the cause of endemic CA-MRSA infection in
Taiwan [24]. Nine clinical isolates of CA-MRSA carrying SCCmec
type IV associated with skin and soft tissue infections have been
identified in Malaysia [25]. Three MRSA were isolated from
patients after 72 hours of hospitalization in a large teaching
hospital in Bangkok, Thailand but the authors noted that these
probably represented HA-MRSA infections [26]. A study
published in 2002 of surveillance for MRSA in Battambang
situated in the province adjacent to, and west of Siem Reap
province reported that no MRSA was detected [27]. Our study is
the first to describe MRSA of any kind in Cambodia. Cases were
drawn from three different northwest Cambodian provinces,
suggesting that considerable dissemination of CA-MRSA has
already occurred. These provinces form the major patient
catchment area for the hospital, and it is possible that CA-MRSA
is present across a more extensive region of Cambodia. The
majority of health care facilities across the country lack the
necessary microbiology facilities to culture clinical specimens, and
there is little or no awareness amongst health care workers of the
possibility of MRSA.
The evidence that the MRSA isolated during this study was CA-
MRSA was compelling and supported by both clinical and
laboratory data. The CA-MRSA positive culture was taken within
48 hours of admission in 16 of the 17 cases from children with
clinical features of S. aureus infection. Thirteen cases appeared to
be sporadic, while two pairs of children resided in each of two
villages although contact or a shared environment could not be
confirmed. We conclude that most infections were indicative of
endemic carriage in the community and represented discrete
episodes of infection, rather than one or more outbreaks. The
criteria used in the developed world that patients should have no
history of recent healthcare contact may be less relevant in our
setting where HA-MRSA has not been reported, but there was no
evidence that CA-MRSA was acquired within a single or small
Table 1. Summary data for antimicrobial susceptibility
profiles of 17 CA-MRSA isolates.
Antimicrobial agent Number of isolates resistant (%)
Chloramphenicol 2 (12%)
Ciprofloxacin 1 (6%)
Clindamycin 13 (77%)
Erythromycin 13 (77%)
Fusidic acid 0
Gentamicin 1 (6%)
Mupirocin 0
Netilmicin 0
Penicillin 17 (100%)
Rifampicin 15 (88%)
Tetracycline 16 (94%)
Trimethoprim-sulfamethoxazole 15 (88%)
Vancomycin 0
doi:10.1371/journal.pone.0006630.t001
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PLoS ONE | www.plosone.org 3 August 2009 | Volume 4 | Issue 8 | e6630Figure 1. Map of Cambodia showing location of residence for 17 children with CA-MRSA infection presenting to the Angkor
Hospital for Children in Siem Reap (A). Zoomed image of the three affected provinces. Numbers in brackets denote the number of children
affected in each village (B).
doi:10.1371/journal.pone.0006630.g001
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individuals. The molecular data on SCCmec type was also
consistent with a community origin for these strains.
Alterations in prescribing practice has occurred over time in
areas where CA-MRSA infection has become endemic, with a
decrease in the use of b-lactam antibiotics as initial empirical
therapy for skin and soft tissue infections and an increased use of a
range of previously second-line antimicrobial agents [28,29]. The
CA-MRSA identified during this study had a high rate of
resistance to several of the oral antibiotics commonly used to
treat mild, community-acquired S. aureus infection. CA-MRSA is
currently responsible for a small proportion of S. aureus infections
overall in our setting, with isolation of MSSA from 289 clinical
samples sent to the diagnostic laboratory over the period of this
study (unpublished data). In view of this, we recommend that
cloxacillin should continue to be used as first-line empiric therapy
for suspected S. aureus infection. However, information regarding
the possibility of CA-MRSA infection should be disseminated to
healthcare workers who should consider this possibility in patients
who deteriorate on appropriate therapy for MSSA infection.
Vancomycin is available through donation at the AHC but is not
available in government-funded hospitals in Cambodia. Possible
alternatives that are available in Cambodia include the fluoro-
quinolones and chloramphenicol.
The clinical presentation of children presenting to our hospital
with CA-MRSA infection represents a comparable spectrum to
that described elsewhere, with a predominance of skin and soft
tissue infections. The common circulating strains of CA-MRSA in
the United States are PVL gene-positive, and an association has
been made between the presence of PVL and skin and soft tissue
infection. This association was absent in our setting, since most
infections were caused by ST 834 which is PVL gene-negative.
The two infections caused by PVL gene-positive ST 121 were
osteomyelitis and soft tissue abscess, respectively.
With increasing rates of MRSA across the world, and with
increasing contact between Cambodian communities and foreign-
ers as a result of post-war humanitarian aid and more recently
tourism, there is a strong possibility that Cambodia will be exposed
to MRSA carriers from the developed world. However, it is not
clear whether the two clones of CA-MRSA identified here arose in
Cambodia or whether they arose elsewhere and were introduced
by a carrier. The finding that MSSA ST 121 is the most common
clone in our setting might suggest that CA-MRSA ST 121 arose
locally, although MSSA ST 121 is also common in nearby
countries including Thailand and China, and MRSA ST 121 has
been described in China. Similarly, ST 834 has been isolated in
Western Australia. The earlier time point for isolation of ST 834
from Cambodia is very weak evidence for the possibility that it
arose there.
In conclusion, this study has identified CA-MRSA in three
neighbouring provinces in the highly resource-restricted setting of
Cambodia. Diagnostic microbiology is not available across most of
the country, but we hypothesize that CA-MRSA may have
become widely disseminated. This potentially major threat to
public health requires urgent investigation. Studies are underway
to define the prevalence of CA-MRSA carriage in the community
and to track the rate of CA-MRSA cases presenting to our hospital
over time.
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